Adapti, Inc. (ADTI) Stock Price & Analysis
Adapti, Inc. (ADTI) fell 23.28% to USD 2.2 as of July 25, 2026 at 13:09 UTC, according to Nexqual real-time market data.
ADTI last closed at USD 2.87; the session ranged USD 2.35–2.35 on volume of 100 shares. Market capitalization is $18.55M, with a 52-week range of USD 0.16–3.5 (PNK). Source: Nexqual, July 25, 2026 at 13:09 UTC.
Key Statistics (as of July 25, 2026 at 13:09 UTC)
| Price | USD 2.2 |
|---|---|
| Change | ▼ 23.28% (down) |
| Previous Close | USD 2.87 |
| Open | USD 2.35 |
| Day Range | USD 2.35 – 2.35 |
| 52-Week Range | USD 0.16 – 3.5 |
| Volume | 100 shares |
| Market Cap | $18.55M |
| Exchange | PNK |
Technical Analysis (ADTI)
Nexqual's technical model rates ADTI "NEUTRAL" based on 4 bullish and 4 bearish signals across 125 daily candles, as of July 25, 2026 at 13:09 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 24.84 (oversold) |
| vs SMA50 | Below (USD 2.43) |
| MACD | 0.06 (positive) |
Analyst Ratings (ADTI)
Wall Street analysts rate ADTI "None", per Nexqual as of July 25, 2026 at 13:09 UTC.
| Consensus Rating | None |
|---|
Earnings (ADTI)
Source: Nexqual, July 25, 2026 at 13:09 UTC.
Financials & Fundamentals (ADTI)
| Total Revenue | $3.66M |
|---|---|
| Revenue Growth (YoY) | +122544.30% |
| Gross Margin | +23.51% |
| Operating Margin | -178.71% |
| Profit Margin | -166.24% |
| ROE | -97.94% |
| Debt / Equity | 93.11 |
| Current Ratio | 0.68 |
| Total Cash | $32,767 |
| Total Debt | $12.57M |
| Free Cash Flow | $-2.52M |
Source: Nexqual, July 25, 2026 at 13:09 UTC.
Financial Health Score (ADTI)
Nexqual rates Adapti, Inc.'s overall financial health "Weak" across five dimensions, as of July 25, 2026 at 13:09 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Weak — $33K cash vs $13M debt |
| Cash Flow | Weak — FCF negative: -$3M, burning cash |
| Efficiency | Critical — ROE -98%, ROA -22.2% |
Ownership (ADTI)
| Insider Ownership | +14.44% |
|---|---|
| Institutional Ownership | +0.06% |
| Shares Outstanding | 8.42M |
| Float | 6.98M |
Source: Nexqual, July 25, 2026 at 13:09 UTC.
Leadership (ADTI)
Adapti, Inc. is led by Adam Nicosia (age 47), CEO, Interim Principal Financial & Accounting Officer and Director, per Nexqual as of July 25, 2026 at 13:09 UTC.
| CEO, Interim Principal Financial & Accounting Officer and Director | Adam Nicosia (age 47) |
|---|---|
| Executive Chairman | Jeffrey Campbell |
| Chief Financial Officer | Benjamin F. Cary |
| Chief Technology Officer | Dan Shupp |
| Chief Revenue Officer | Omar Karim (age 44) |
From Adapti, Inc.'s Latest SEC 10-K Filing (filed 2025-07-03)
Key Strengths & Strategy (as disclosed to the SEC)
- Adapti, Inc. engages in the sale and brand development of health and beauty products.
- The company also acquires or licenses performing brands to add to its portfolio of products and brands.
- It sells cosmetics under the Dermacia brand through its related websites and other online marketplaces.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GREH | Green Rain Energy Holdings Inc. | USD 0.01 | ▼ 4.84% |
| SPONF | SPONSORSONE INC | USD 0 | ▲ 0% |
| ODYY | Odyssey Health Inc. | USD 0.01 | ▲ 16.67% |
| CPMD | Cannapharmarx Inc. | USD 0 | ▲ 0% |
| EVAHF | EGF THERAMED HEALTH CORP. | USD 0.03 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 13:09 UTC. This page is informational and not investment advice.